Advertisement

Tenet Healthcare Corporation THC

Set alert

Price alert · THC

All alert types
273.25 USD +2.68 +0.99%

At close · Oct 30

273.25 0.00 0.00%

After hours · Oct 30, 4:34 PM ET

Bid
273.00 × 100
Ask
273.37 × 100
265.58 Day range 274.09
161.37 52-week range 280.77
YTD
+37.51%
1 year
+30.98%
Open
266.51
Prev close
270.57
Mkt cap
22.00B
Vol
1.21M
Avg vol
748.23K
EPS
25.88
P/E
10.56
Div yield
0.00%
More statistics
Low
265.58
High
274.09
Forward P/E
12.84
Beta
1.20
Short ratio
2.63
Inst. own
101.92%
Dividend
0.00
Ex-div date
Mar 12, 2000
Earnings
Feb 10, 2027
50-d avg
264.86
200-d avg
219.82
1y target
286.41

5Y chart

Chart tools
Interval

Events in this range
  • Oct 28, 2025Earnings: 3.7; estimate 3.34; surprise 10.78%
  • Feb 11, 2026Earnings: 4.7; estimate 4.07; surprise 15.48%
  • Apr 30, 2026Earnings: 4.82; estimate 4.17; surprise 15.59%
  • Jul 22, 2026Earnings: 6.12; estimate 4.26; surprise 43.66%
  • Jul 28, 2026Rating: Truist Securities · Buy → Buy
  • Aug 3, 2026Rating: Wells Fargo · Overweight → Overweight
  • Sep 18, 2026Rating: Leerink Partners · Outperform → Outperform
  • Sep 23, 2026Rating: BMO Capital · — → Market Perform
  • Oct 16, 2026Rating: Guggenheim · Buy → Buy
  • Oct 29, 2026Earnings: 6.64; estimate 4.68; surprise 41.88%
  • Oct 30, 2026Rating: Guggenheim · Buy → Buy
Signals (78)
NameDateAgo
SMA: BullishOct 12, 20262 weeks ago
SMA: BearishSep 21, 20261 month ago
RSI: OverboughtAug 10, 20262 months ago
SMA: BullishJul 20, 20263 months ago
SMA: BearishJul 13, 20263 months ago
MACD: Buy SignalJul 6, 20263 months ago
SMA: BullishJun 29, 20264 months ago
SMA: BullishJun 22, 20264 months ago
SMA: BearishMay 18, 20265 months ago
SMA: BullishMay 11, 20265 months ago
MACD: Sell SignalMar 23, 20267 months ago
SMA: BearishMar 16, 20267 months ago
SMA: BearishMar 16, 20267 months ago
MACD: Buy SignalFeb 16, 20268 months ago
SMA: BullishFeb 2, 20269 months ago
SMA: BullishFeb 2, 20269 months ago
SMA: BearishJan 19, 20269 months ago
SMA: BearishDec 8, 202510 months ago
SMA: BullishNov 24, 202511 months ago
SMA: BearishNov 10, 202511 months ago
MACD: Sell SignalNov 10, 202511 months ago
MACD: Buy SignalAug 18, 20251 year ago
SMA: BullishAug 11, 20251 year ago
MACD: Sell SignalAug 4, 20251 year ago
SMA: BearishJul 21, 20251 year ago
SMA: BullishApr 28, 20251 year ago
SMA: BullishApr 28, 20251 year ago
MACD: Buy SignalApr 28, 20251 year ago
SMA: BearishMar 31, 20251 year ago
SMA: BullishMar 24, 20251 year ago
SMA: BearishFeb 17, 20251 year ago
SMA: BullishJan 20, 20251 year ago
SMA: BearishNov 18, 20241 year ago
SMA: BearishNov 11, 20241 year ago
SMA: BullishNov 4, 20241 year ago
SMA: BearishOct 21, 20242 years ago
SMA: BullishOct 14, 20242 years ago
SMA: BearishSep 30, 20242 years ago
MACD: Sell SignalSep 30, 20242 years ago
RSI: OverboughtSep 16, 20242 years ago
RSI: OverboughtAug 5, 20242 years ago
SMA: BullishJul 22, 20242 years ago
MACD: Buy SignalJul 22, 20242 years ago
SMA: BearishJul 15, 20242 years ago
MACD: Sell SignalJul 15, 20242 years ago
SMA: BullishApr 29, 20242 years ago
MACD: Buy SignalApr 29, 20242 years ago
RSI: OverboughtApr 29, 20242 years ago
MACD: Sell SignalApr 22, 20242 years ago
SMA: BearishApr 15, 20242 years ago
RSI: OverboughtJan 29, 20242 years ago
SMA: BullishNov 27, 20232 years ago
MACD: Buy SignalNov 27, 20232 years ago
SMA: BullishNov 13, 20232 years ago
SMA: BearishSep 11, 20233 years ago
SMA: BearishSep 4, 20233 years ago
SMA: BullishAug 28, 20233 years ago
MACD: Sell SignalJul 31, 20233 years ago
SMA: BearishJul 24, 20233 years ago
SMA: BullishMar 27, 20233 years ago
SMA: BearishMar 6, 20233 years ago
SMA: BullishJan 23, 20233 years ago
SMA: BullishDec 19, 20223 years ago
MACD: Buy SignalDec 12, 20223 years ago
RSI: OversoldOct 17, 20224 years ago
MACD: Sell SignalSep 19, 20224 years ago
SMA: BearishSep 12, 20224 years ago
SMA: BullishSep 5, 20224 years ago
MACD: Buy SignalSep 5, 20224 years ago
MACD: Sell SignalAug 29, 20224 years ago
SMA: BearishAug 22, 20224 years ago
MACD: Buy SignalAug 15, 20224 years ago
SMA: BullishJul 18, 20224 years ago
RSI: OversoldJun 13, 20224 years ago
SMA: BearishApr 4, 20224 years ago
SMA: BullishFeb 7, 20224 years ago
SMA: BearishJan 17, 20224 years ago
SMA: BullishJan 10, 20224 years ago

Key statistics

Market cap
21.80B
Enterprise value
36.40B
Trailing P/E
10.46
Forward P/E
12.84
PEG ratio
1.88
Price / sales
0.98
Price / book
4.68
EPS (TTM)
25.88
Beta
1.20
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
13.09%
Revenue (TTM)
22.15B
Revenue growth
6.50%
Free cash flow
2.00B
Total cash
2.67B
Total debt
13.24B
Return on equity
41.70%
Shares outstanding
80.52M
Short % of float
2.68%
50-day average
264.86
200-day average
219.82

Analyst view

Consensus: buy

Buy
Price target (mean) 286.41 +4.8% upside
Target (low)
260.00
Target (mean)
286.41
Target (high)
315.00
Ratings (0m) 23 19 buy · 4 hold · 0 sell
  • Strong buy5
  • Buy14
  • Hold4
  • Sell0
  • Strong sell0

Next earnings

Feb 10, 2027

Expected Feb 10, 2027. Consensus EPS estimate 5.67.

Earnings history

Financials — quick view

All financials
THC Revenue — quarterly 6.28B
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
THC Net income — quarterly 1.00B
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
THC EPS — quarterly 12.48
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026

Earnings

THC recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 10, 2027Dec 30, 20265.43———
Oct 29, 2026Sep 30, 20264.686.64+1.96+41.88%
Jul 22, 2026Jun 30, 20264.266.12+1.86+43.66%
Apr 30, 2026Mar 31, 20264.174.82+0.65+15.59%
Feb 11, 2026Dec 31, 20254.074.70+0.63+15.48%
Oct 28, 2025Sep 30, 20253.343.70+0.36+10.78%

Upgrades / downgrades

THC analyst upgrades and downgrades
DateFirmActionFromTo
Oct 30, 2026GuggenheimmainBuyBuy
Oct 16, 2026GuggenheimmainBuyBuy
Sep 23, 2026BMO Capitalinit—Market Perform
Sep 18, 2026Leerink PartnersmainOutperformOutperform
Aug 3, 2026Wells FargomainOverweightOverweight
Jul 28, 2026Truist SecuritiesmainBuyBuy

About Tenet Healthcare Corporation

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; pediatric quaternary care services through heart, liver, and kidney transplants programs; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging technology, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services comprising orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. Further, the company operates acute care and specialty hospitals, off-campus emergency departments, imaging centers, urgent care centers, and micro-hospitals, as well as ambulatory surgery centers and surgical hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.

Sector
Healthcare
Industry
Medical Care Facilities
Country
United States

News

Your note

Sign in to keep a note on THC — it syncs with the Stock Master app.

Insider holders

THC insider holders
InsiderRelationLatest transactionDateShares held
ARBOUR PAOLA MChief Technology OfficerSaleJul 26, 202618,413
BIERMAN JAMES LDirectorSaleJul 26, 202631,604
FISHER RICHARD W.DirectorConversion of Exercise of derivative securityMay 21, 20269,632
FITZGERALD MEGHANDirectorConversion of Exercise of derivative securityMay 21, 202617,087
HANEY CECIL D.DirectorStock GiftAug 27, 202612,403
MARK RICHARD JDirectorSaleSep 9, 202625,121

Institution ownership

THC institution ownership
Holder% heldSharesValueReported
Blackrock Inc.10.86%8,743,0052.37BJun 29, 2026
Price (T.Rowe) Associates Inc9.88%7,957,4492.15BJun 29, 2026
Boston Partners5.51%4,433,3601.20BJun 29, 2026
Vanguard Portfolio Management LLC5.26%4,238,1081.15BJun 29, 2026
FMR, LLC4.96%3,994,5451.08BJun 29, 2026
Vanguard Capital Management LLC4.84%3,894,1891.05BJun 29, 2026

Fund ownership

THC fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Mid-Cap ETF3.56%2,868,116776.69MSep 29, 2026
TR PRICE-Price (T.Rowe) U.S. Value Equity Trust3.53%2,840,356769.17MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.40%2,734,962740.63MJun 29, 2026
T. Rowe Price Value Fund, Inc.2.60%2,092,106566.54MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.45%1,975,296534.91MJun 29, 2026
John Hancock Funds III-Disciplined Value Mid Cap Fund1.84%1,483,123401.63MAug 30, 2026
Advertisement